文献速递慢性静脉疾病静脉血栓栓塞

编织型与激光切割型镍钛支架用于血栓后综合征股总静脉的对比研究

Braided or laser-cut self-expanding nitinol stents for the common femoral vein in patients with post-thrombotic syndrome.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-09-02

基于瑞士与Arnsberg静脉支架注册研究,纳入150例血栓后综合征患者,比较激光切割型(n=101)与编织型(n=49)镍钛支架跨越腹股沟韧带置入股总静脉的12个月通畅率。

要点

  • 编织型镍钛支架12个月一期通畅率86.7%,优于激光切割型的67.3%。
  • 两组二期通畅率无显著差异,激光切割组出现4例症状性支架断裂。
  • Villalta评分中位改善4分,两组间无显著差异。

核心结论

  • 编织型镍钛支架用于股总静脉闭塞在12个月一期通畅率上优于激光切割型支架。
  • 需进一步研究证实编织型支架长期通畅且可能更少发生断裂。

研究设计与样本

  • 来自瑞士与Arnsberg静脉支架注册研究的回顾性分析,纳入150例血栓后综合征患者。
  • 平均年龄44±16岁,女性占48%;激光切割型支架101例,编织型支架49例。
  • 支架跨越腹股沟韧带置入股总静脉,随访包括双功能超声和临床评分评估。

主要发现

  • 平均植入支架数2.6±1.7枚;近端着陆区为下腔静脉32例(21%)、髂静脉106例(76%)、股总静脉5例(3%)。
  • Villalta评分从基线至末次随访中位改善4分(四分位距2-6分),两组间无显著差异。
  • 症状性股总静脉支架断裂见于4例(4%)激光切割型支架患者,编织型支架患者中未见。

临床怎么用

  • 对于血栓后综合征累及股总静脉需支架置入的患者,编织型镍钛支架可能提供更优的12个月一期通畅率。
  • 激光切割型支架跨越腹股沟韧带置入股总静脉时需警惕支架断裂风险。

局限性

  • 原文未报告研究的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic obstruction of the common femoral vein in patients with post-thrombotic syndrome after iliofemoral or iliocaval deep vein thrombosis has remained a challenge for endovascular treatment. The patency rates and clinical outcomes of laser-cut and braided nitinol stents extending to the common femoral vein have not yet been studied. METHODS: From the Swiss and Arnsberg Venous Stent Registries, we included 150 patients with post-thrombotic syndrome (mean age, 44 ± 16 years; 48% women) with laser-cut (n = 101) or braided nitinol (n = 49) stents placed into the common femoral vein across the inguinal ligament. Routine follow-up included duplex ultrasound examinations and assessment of clinical scores. The primary study outcomes were the primary and secondary patency rates at 12 months. RESULTS: Overall, the mean number of implanted stents was 2.6 ± 1.7. The proximal stent landing zone was the inferior vena cava in 32 patients (21%), the iliac vein in 106 patients (76%), and the common femoral vein in 5 patients (3%). The primary patency rate was 67.3% (95% confidence interval [CI], 58.0%-76.6%) in the laser-cut group and 86.7% (95% CI, 75.3%-98.1%) in the braided stent group (log-rank, P = .016). The corresponding secondary patency rates were 93.9% (95% CI, 89.2%-98.6%) and 100% (log-rank, P = .10). The median improvement in the Villalta score from baseline to the latest follow-up was 4 points (interquartile range, 2-6 points), without significant differences between the two groups. Symptomatic common femoral vein stent fractures were observed in four patients (4%) with laser-cut stents but in no patient with braided stents. CONCLUSIONS: The use of braided nitinol stents for common femoral vein obstruction appeared to be associated with favorable primary patency rates at 12 months compared with laser-cut nitinol stents. Further studies are needed to confirm that braided nitinol stents remain patent and might be less prone to fractures in the long term.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Moeri L, Lichtenberg M, Gnanapiragasam S, et al. Braided or laser-cut self-expanding nitinol stents for the common femoral vein in patients with post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32890743. doi:10.1016/j.jvsv.2020.08.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。